Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Melanoma × Cholecalciferol × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colonic Neoplasms 3 Rectal Neoplasms 2 Leukemia, Myeloid, Acute 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Vitamin D Deficiency 1 Renal Insufficiency, Chronic 1 Pulmonary Disease, Chronic Obstructive 1 Prostatic Neoplasms 1 Precancerous Conditions 1 Osteoporosis 1 Obesity 1 Neurofibromatosis 1 1 Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Melanoma 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1 Leukemia, B-Cell 1 Leukemia 1 Healthy, no Evidence of Disease 1 Congenital Abnormalities 1 Cardiovascular Diseases 1 Bone Diseases, Metabolic 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

pembrolizumab 45 Ipilimumab 39 Cyclophosphamide 38 Nivolumab 33 aldesleukin 26 fludarabine 19 Vemurafenib 19 Interleukin-2 19 dabrafenib 15 Temozolomide 15 fludarabine phosphate 13 trametinib 12 Radiosurgery 9 Dacarbazine 9 spartalizumab 8 cobimetinib 8 binimetinib 8 Radiotherapy 8 poly ICLC 6 encorafenib 6 Introns 6 CTLA-4 Antigen 6 Biopsy 6 montanide ISA 51 5 atezolizumab 4 Interferon alpha-2 4 Immunohistochemistry 4 Celecoxib 4 Bevacizumab 4 tovorafenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01264874 2018-01-31

MelaViD

European Institute of Oncology

Phase 3 Terminated

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡